References
- SiegelRLMillerKDJemalACancer statistics, 2015CA Cancer J Clin201565152925559415
- FisherBBrownAMamounasEEffect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18J Clin Oncol1997157248324939215816
- FisherBBryantJWolmarkNEffect of preoperative chemotherapy on the outcome of women with operable breast cancerJ Clin Oncol1998168267226859704717
- WolmarkNWangJMamounasEBryantJFisherBPreoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18J Natl Cancer Inst Monogr20013096102
- AmbrosVThe functions of animal microRNAsNature2004431700635035515372042
- BartelDPMicroRNAs: genomics, biogenesis, mechanism, and functionCell2004116228129714744438
- HeLHannonGJMicroRNAs: small RNAs with a big role in gene regulationNat Rev Genet20045752253115211354
- JungEJSantarpiaLKimJPlasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patientsCancer2012118102603261422370716
- LiQLiuMMaFCirculating miR-19a and miR-205 in serum may predict the sensitivity of luminal A subtype of breast cancer patients to neoadjuvant chemotherapy with epirubicin plus paclitaxelPLoS One201498e10487025137071
- WangHTanGDongLCirculating MiR-125b as a marker predicting chemoresistance in breast cancerPLoS One201274e3421022523546
- WuXSomloGYuYDe novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancerJ Transl Med2012104222400902
- ZhaoRWuJJiaWPlasma miR-221 as a predictive biomarker for chemoresistance in breast cancer patients who previously received neoadjuvant chemotherapyOnkologie2011341267568022156446
- MoMHChenLFuYWangWFuSWCell-free circulating miRNA biomarkers in cancerJ Cancer2012343244823074383
- TurchinovichAWeizLLangheinzABurwinkelBCharacterization of extracellular circulating microRNANucleic Acids Res201139167223723321609964
- VickersKCPalmisanoBTShoucriBMShamburekRDRemaleyATMicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteinsNat Cell Biol201113442343321423178
- LawrieCHGalSDunlopHMDetection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphomaBr J Haematol2008141567267518318758
- KastlLBrownISchofieldACmiRNA-34a is associated with docetaxel resistance in human breast cancer cellsBreast Cancer Res Treat2012131244545421399894
- PogribnyIPFilkowskiJNTryndyakVPGolubovAShpylevaSIKovalchukOAlterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatinInt J Cancer201012781785179420099276
- YangGWuDZhuJUpregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1Oncol Rep201330287788923760062
- YangQWangYLuXMiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cellsOncotarget2015653268327925605244
- KojimaHUemuraTStrong and rapid induction of osteoblast differentiation by Cbfa1/Til-1 overexpression for bone regenerationJ Biol Chem200528042944295315537653
- KomoriTRegulation of skeletal development by the Runx family of transcription factorsJ Cell Biochem200595344545315786491
- TaipaleenmäkiHBrowneGAkechJTargeting of Runx2 by miR-135 and miR-203 impairs progression of breast cancer and metastatic bone diseaseCancer Res20157571433144425634212
- OnoderaYMikiYSuzukiTRunx2 in human breast carcinoma: its potential roles in cancer progressionCancer Sci2010101122670267520946121
- OzakiTWuDSugimotoHNagaseHNakagawaraARunt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damageCell Death Dis20134e61023618908